The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug Response
Multiple myeloma (MM) is a clonal plasma cell malignancy that develops primarily in the bone marrow (BM), where reciprocal interactions with the BM niche foster MM cell survival, growth, and drug resistance. MM cells furthermore reshape the BM to their own needs by affecting the different BM stromal...
Main Authors: | Eva De Smedt, Hui Lui, Ken Maes, Kim De Veirman, Eline Menu, Karin Vanderkerken, Elke De Bruyne |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2018.00566/full |
Similar Items
-
Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma
by: Elke De Bruyne, et al.
Published: (2013-04-01) -
Chondrosarcome : mécanismes de résistance aux traitements conventionnels et thérapies innovantes
by: Lhuissier, Eva
Published: (2017) -
Tackling malignant melanoma epigenetically: histone lysine methylation
by: Elias Orouji, et al.
Published: (2018-11-01) -
Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effects
by: Lien De Beck, et al.
Published: (2018-10-01) -
Disruption of Methionine Metabolism in Drosophila melanogaster Impacts Histone Methylation and Results in Loss of Viability
by: Mengying Liu, et al.
Published: (2016-01-01)